Market Value3,105,401,652
Total Holdings58
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
KRON / Kronos Bio, Inc.
GRPH / Graphite Bio, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
ALLO / Allogene Therapeutics, Inc.
GBIO / Generation Bio Co.
THRD / Third Harmonic Bio, Inc.
KURA / Kura Oncology, Inc.
MORF / Morphic Holding, Inc.
NUVB / Nuvation Bio Inc.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
DYN / Dyne Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
APLS / Apellis Pharmaceuticals, Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
OVID / Ovid Therapeutics Inc.
KDNY / Chinook Therapeutics Inc
BEAM / Beam Therapeutics Inc.
CGEM / Cullinan Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
AVIR / Atea Pharmaceuticals, Inc.
PRME / Prime Medicine, Inc.
PRTA / Prothena Corporation plc
BCAB / BioAtla, Inc.
DSGN / Design Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
ARYD / ARYA Sciences Acquisition Corp IV
GERN / Geron Corporation
IMTX / Immatics N.V.
ERAS / Erasca, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
PSTX / Poseida Therapeutics, Inc.
SELB / Selecta Biosciences Inc
ZYME / Zymeworks Inc.
DTIL / Precision BioSciences, Inc.
VYGR / Voyager Therapeutics, Inc.
ABEO / Abeona Therapeutics Inc.
AVEO / AVEO Pharmaceuticals Inc
EWTX / Edgewise Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
/ VENTYX BIOSCIENCES INC
ARVN / Arvinas, Inc.
ACET / Adicet Bio, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
ALEC / Alector, Inc.
PRAX / Praxis Precision Medicines, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
HOOK / HOOKIPA Pharma Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
SRPT / Sarepta Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
CYT / Cyteir Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
SURF / Surface Oncology Inc
RLAY / Relay Therapeutics, Inc.
NGM / NGM Biopharmaceuticals, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
PRQR / ProQR Therapeutics N.V.
SWTX / SpringWorks Therapeutics, Inc.
MGNX / MacroGenics, Inc.
ALGS / Aligos Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)